Borst J, Spits H, de Vries J, Pessano S, Rovera G, Terhorst C
Hybridoma. 1983;2(3):265-74. doi: 10.1089/hyb.1983.2.265.
S5.7 recognizes a 20 kD cell surface protein which is present on T lymphocytes. S5.7 binds to a nonglycosylated protein, which can be labeled by cell-surface radioiodination and by a hydrophobic reagent [125I]-iodo-5-naphthyl-1-azide (INA). As the T-lymphocyte-specific T3 complex was found to contain a nonglycosylated 20 kD species, and since this 20 kD T3 form can be labeled preferentially by INA, a comparison between T3 and S5.7 was made. Isoelectric focusing experiments showed, however, that the two proteins are different. Moreover, the S5.7 monoclonal antibody does not block CML, is not mitogenic, reacts with immature cells of several hemopoietic lineages, and differs in that respect from anti-T3 monoclonal antibodies.
S5.7识别一种存在于T淋巴细胞上的20kD细胞表面蛋白。S5.7与一种非糖基化蛋白结合,该蛋白可通过细胞表面放射性碘化和疏水性试剂[125I]-碘-5-萘基-1-叠氮化物(INA)进行标记。由于发现T淋巴细胞特异性T3复合物含有一种非糖基化的20kD成分,并且由于这种20kD的T3形式可被INA优先标记,因此对T3和S5.7进行了比较。然而,等电聚焦实验表明这两种蛋白是不同的。此外,S5.7单克隆抗体不阻断慢性粒细胞白血病,无促有丝分裂作用,与几种造血谱系的未成熟细胞发生反应,在这方面与抗T3单克隆抗体不同。